NEA Management Company, LLC - Q2 2022 holdings

$1.95 Billion is the total value of NEA Management Company, LLC's 57 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 7.0% .

 Value Shares↓ Weighting
BHG  BRIGHT HEALTH GROUP INC$397,146,000
-5.7%
218,212,1260.0%20.40%
+67.7%
COUR  COURSERA INC$225,005,000
+574.8%
15,867,7690.0%11.56%
+1100.0%
SellIONQ INC$115,413,000
-69.1%
26,350,067
-10.0%
5.93%
-45.1%
BuyARCELLX INC$112,703,000
+56.1%
6,750,264
+4.9%
5.79%
+177.5%
CRSP  CRISPR THERAPEUTICS AGnamen akt$96,624,000
-73.6%
1,590,0020.0%4.96%
-53.0%
NET  CLOUDFLARE INC$82,141,000
-63.5%
1,877,5100.0%4.22%
-35.0%
MIRM  MIRUM PHARMACEUTICALS INC$81,495,000
-11.6%
4,187,8010.0%4.19%
+57.1%
GLUE  MONTE ROSA THERAPEUTICS INC$74,490,000
-31.0%
7,703,2050.0%3.83%
+22.6%
 BERKSHIRE GREY INC$55,429,000
-49.7%
38,226,6210.0%2.85%
-10.5%
CTIC BuyCTI BIOPHARMA CORP$48,042,000
-51.9%
8,047,228
+12.7%
2.47%
-14.4%
NKTX BuyNKARTA INC$44,003,000
+33.1%
3,571,640
+22.9%
2.26%
+136.6%
AUPH  AURINIA PHARMACEUTICALS INC$39,897,000
-18.8%
3,969,8340.0%2.05%
+44.3%
SVRA  SAVARA INC$36,690,000
+16.0%
24,137,9310.0%1.88%
+106.4%
TRVI BuyTREVI THERAPEUTICS INC$31,959,000
+86.4%
11,373,174
+406375.1%
1.64%
+231.5%
DM  DESKTOP METAL INC$31,697,000
-53.6%
14,407,5940.0%1.63%
-17.5%
IVA BuyINVENTIVA SAads$31,599,000
+112.7%
5,572,953
+329.1%
1.62%
+278.3%
ADAP BuyADAPTIMMUNE THERAPEUTICS PLCadr$29,040,000
-17.5%
17,082,612
+0.0%
1.49%
+46.9%
AVEO  AVEO PHARMACEUTICALS INC$25,931,000
+17.4%
3,952,9570.0%1.33%
+108.8%
OYST  OYSTER PT PHARMA INC$25,656,000
-62.8%
5,925,2870.0%1.32%
-33.8%
GERN  GERON CORP$25,294,000
+14.0%
16,318,6810.0%1.30%
+102.7%
 BUZZFEED INC$23,614,000
-67.5%
15,333,8920.0%1.21%
-42.2%
 MINERVA SURGICAL INC$23,505,000
-42.0%
10,001,9370.0%1.21%
+3.2%
VRNA  VERONA PHARMA PLCads$21,405,000
-16.0%
5,108,5630.0%1.10%
+49.3%
RYTM  RHYTHM PHARMACEUTICALS INC$20,386,000
-64.0%
4,912,3060.0%1.05%
-36.0%
AKUS  AKOUOS INC$20,160,000
-1.3%
4,298,4880.0%1.04%
+75.4%
 NEXTNAV INC$18,589,000
-66.3%
8,189,1560.0%0.96%
-40.1%
PANW NewPALO ALTO NETWORKS INC$15,389,00032,796
+100.0%
0.79%
VTGN  VISTAGEN THERAPEUTICS INC$14,346,000
-29.0%
16,302,5960.0%0.74%
+26.2%
CVRX  CVRX INC$14,249,000
+0.3%
2,370,8580.0%0.73%
+78.5%
CSBR  CHAMPIONS ONCOLOGY INC$13,710,000
-1.6%
1,713,7200.0%0.70%
+75.1%
STSA  SATSUMA PHARMACEUTICALS INC$13,012,000
+9.0%
3,142,9580.0%0.67%
+93.6%
RPHM  RENEO PHARMACEUTICALS INC$12,685,000
-9.9%
4,786,9210.0%0.65%
+60.6%
AFMD  AFFIMED NV$12,261,000
-36.6%
4,426,4880.0%0.63%
+12.7%
INZY  INOZYME PHARMA INC$10,494,000
+5.0%
2,444,3790.0%0.54%
+86.5%
MILE  METROMILE INC$8,610,000
-30.5%
9,384,2850.0%0.44%
+23.5%
BDTX  BLACK DIAMOND THERAPEUTICS INC$8,487,000
-11.2%
3,449,8450.0%0.44%
+58.0%
GLBE  GLOBAL E ONLINE LTD$7,920,000
-40.3%
436,2820.0%0.41%
+6.3%
NewSENTI BIOSCIENCES INC$7,455,0004,429,725
+100.0%
0.38%
OBSV  OBSEVA SA$7,384,000
+6.6%
4,586,5630.0%0.38%
+89.5%
BILL  BILL COM HLDGS INC$6,904,000
-51.5%
66,1000.0%0.36%
-13.6%
ALLK  ALLAKOS INC$6,776,000
-45.1%
2,164,7040.0%0.35%
-2.2%
GLYC  GLYCOMIMETICS INC$5,434,000
-47.6%
9,089,0410.0%0.28%
-6.7%
MEIP  MEI PHARMA INC$5,163,000
+0.4%
8,533,0720.0%0.26%
+79.1%
 XERIS BIOPHARMA HOLDINGS INC$5,000,000
-39.8%
3,246,7850.0%0.26%
+7.1%
SYBX  SYNLOGIC INC$4,864,000
-52.1%
4,229,4100.0%0.25%
-14.7%
BuyAIRSPAN NETWORKS HOLDINGS INC$4,589,000
+2.8%
1,534,633
+0.0%
0.24%
+82.9%
LXRX  LEXICON PHARMACEUTICALS INC$4,431,000
-11.0%
2,382,2860.0%0.23%
+58.3%
PHAS  PHASEBIO PHARMACEUTICALS INC$3,986,000
-54.5%
6,643,7020.0%0.20%
-19.0%
MRKR  MARKER THERAPEUTICS INC$3,536,000
-25.0%
10,714,2850.0%0.18%
+33.8%
EAR BuyEARGO INC$3,399,000
-85.8%
4,520,849
+0.0%
0.18%
-74.7%
RGLS SellREGULUS THERAPEUTICS INC$2,991,000
-30.5%
1,445,115
-90.0%
0.15%
+24.2%
UP  WHEELS UP EXPERIENCE INC$2,069,000
-37.3%
1,061,2590.0%0.11%
+11.6%
IMRA SellIMARA INC$1,228,000
-80.3%
1,006,722
-69.6%
0.06%
-65.0%
ADXN BuyADDEX THERAPEUTICS LTDsponsored ads$1,083,000
+18.5%
941,448
+423.0%
0.06%
+115.4%
TCON  TRACON PHARMACEUTICALS INC$693,000
-24.0%
346,7190.0%0.04%
+38.5%
LUMO SellLUMOS PHARMA INC$503,000
-68.1%
65,374
-61.0%
0.03%
-42.2%
AKTX  AKARI THERAPEUTICS PLCadr$452,000
-16.8%
452,1670.0%0.02%
+43.8%
GNCA ExitGENOCEA BIOSCIENCES INC$0-10,376,936
-100.0%
-0.38%
ExitROBINHOOD MKTS INC$0-47,664,177
-100.0%
-18.60%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GLYCOMIMETICS INC39Q3 20237.6%
AURINIA PHARMACEUTICALS INC37Q3 20235.0%
CHAMPIONS ONCOLOGY INC33Q3 20231.2%
LEXICON PHARMACEUTICALS INC32Q3 20232.0%
ADAPTIMMUNE THERAPEUTICS PLC31Q3 20239.3%
TREVENA INC31Q3 20213.3%
AKARI THERAPEUTICS PLC31Q2 20230.3%
ARDELYX INC29Q3 202111.9%
RIGEL PHARMACEUTICALS INC29Q2 20200.6%
EPIZYME INC28Q1 20209.6%

View NEA Management Company, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-12

View NEA Management Company, LLC's complete filings history.

Compare quarters

Export NEA Management Company, LLC's holdings